Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

BACKGROUND: Sorafenib has been approved in the indication of unresectable hepatocellular carcinoma, but there are many cases in which administration of the drug is discontinued due to severe side effects. In this study, we compared the characteristics of patients who continued and discontinued soraf...

Full description

Saved in:
Bibliographic Details
Main Authors: Nojiri, Shunsuke, Kusakabe, Atsunori, Fujiwara, Kei, Shinkai, Noboru, Matsuura, Kentaro, Iio, Etsuko, Miyaki, Tomokatsu, Nomura, Tomoyuki, Sobue, Satoshi, Sano, Hitoshi, Hasegawa, Izumi, Ohno, Tomoyoshi, Takahashi, Yoshitsugu, Orito, Etsuro, Joh, Takashi
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2012
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534393/
https://ncbi.nlm.nih.gov/pubmed/23293537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S38684
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items